Park National Corp OH increased its holdings in Danaher Corporation (NYSE: DHR) by 6.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 90,107 shares of the conglomerate's stock after buying an additional 5,678 shares during the quarter. Park

Rockland Trust Co. raised its position in Danaher Corporation (NYSE: DHR) by 1,318.0% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 94,026 shares of the conglomerate's stock after buying an additional 87,395 shares during the quarter. Rockland Trust Co.'s holdings in Danaher were worth $20,831,000

Eastover Investment Advisors LLC bought a new stake in Danaher Corporation (NYSE: DHR) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,185 shares of the conglomerate's stock, valued at approximately $1,149,000. A number of other hedge funds have also recently

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and Danaher (DHR). But which of these two stocks is more attractive to value investors?

MassMutual Private Wealth and Trust FSB lifted its stake in shares of Danaher Corporation (NYSE: DHR) by 142.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 112,808 shares of the conglomerate's stock after acquiring an additional 66,309 shares during the period. MassMutual Private Wealth and

WASHINGTON, Oct. 1, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that, effective today, Julie Sawyer Montgomery has assumed the roles of President and Chief Executive Officer and has joined Danaher's Board of Directors, as previously announced on August 3, 2026. Since joining the Company in 2017, Ms.

Danaher's Biotechnology segment posts 4% sales growth, but tough comparisons and shipment timing could test its momentum.

Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation. Given the volume of inquiries landing on our desks, we compiled this guide to answer a mix of the most frequent and most interesting questions we have received regarding our Healthcare Technology and Innovation Index (HTEC).

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Danaher Corporation (NYSE: DHR). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in Danaher stock on August 31st. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account. Representative Kevin Hern also recently made the following trade(s): Sold

WASHINGTON, Sept. 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2026 on Wednesday, October 21, 2026 beginning at 8:00 a.m.